Literature DB >> 15253564

Construction of an artificial immunogen, a candidate DNA vaccine encoding multiple CTL epitopes of HIV-1.

S I Bazhan1, P A Belavin, S V Seregin, N K Danilyuk, I N Babkina, L I Karpenko, N A Nekrasova, L R Lebedev, A P Agafonov, G M Ignat'ev, A A Il'ichev, L S Sandakhchiev.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15253564     DOI： 10.1023/b:dobi.0000025558.70018.4a

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  15 in total

1.  Is an HIV vaccine possible?

Authors:  A J McMichael; T Hanke
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

2.  Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines.

Authors:  B D Livingston; M Newman; C Crimi; D McKinney; R Chesnut; A Sette
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

3.  [Design of recombinant-stable plasmids of the pFH series].

Authors:  N K Daniliuk; O I Serpinskiĭ; A N Siniakov
Journal:  Bioorg Khim       Date:  1991-01

Review 4.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs.

Authors:  J Sidney; H M Grey; R T Kubo; A Sette
Journal:  Immunol Today       Date:  1996-06

5.  A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors:  J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

Authors:  T Hanke; J Schneider; S C Gilbert; A V Hill; A McMichael
Journal:  Vaccine       Date:  1998-02       Impact factor: 3.641

7.  Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.

Authors:  L Wagner; O O Yang; E A Garcia-Zepeda; Y Ge; S A Kalams; B D Walker; M S Pasternack; A D Luster
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

8.  Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.

Authors:  S A Thomson; S L Elliott; M A Sherritt; K W Sproat; B E Coupar; A A Scalzo; C A Forbes; A M Ladhams; X Y Mo; R A Tripp; P C Doherty; D J Moss; A Suhrbier
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

9.  [The characteristics of the long-term continuous cultivation of a cell line chronically infected with the human immunodeficiency virus type-1].

Authors:  O A Mamaeva; O A Pliasunova; T R Proniaeva; A G Pokrovskiĭ; V K Tkachev; E V Karamov; I A Rudneva
Journal:  Vopr Virusol       Date:  1991 Nov-Dec

10.  [Searching for local similarities between HIV-1 and human proteins. Application to vaccines].

Authors:  A Z Maksiutov; A G Bachinskiĭ; S I Bazhan
Journal:  Mol Biol (Mosk)       Date:  2002 May-Jun
View more
  1 in total

1.  CombiHIVvac vaccine which contains polyepitope B and T- cell immunogens of HIV-1.

Authors:  L I Karpenko; S I Bazhan; A M Eroshkin; L R Lebedev; R V Uzhachenko; N A Nekrasova; O A Plyasunova; P A Belavin; S V Seregin; N K Danilyuk; E D Danilenko; B N Zaitsev; V I Masicheva; A A Ilyichev; L S Sandakhchiev
Journal:  Dokl Biochem Biophys       Date:  2007 Mar-Apr       Impact factor: 0.788
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.